Wave Life Sciences Ltd.
WVE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,710 | $536 | $552 | $163 |
| - Cash | $302 | $200 | $88 | $151 |
| + Debt | $25 | $32 | $38 | $30 |
| Enterprise Value | $1,434 | $368 | $501 | $42 |
| Revenue | $108 | $113 | $4 | $41 |
| % Growth | -4.4% | 3,005.1% | -91.1% | – |
| Gross Profit | $108 | $113 | $4 | $41 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$102 | -$59 | -$153 | -$117 |
| % Margin | -93.9% | -51.9% | -4,182.1% | -286.1% |
| Net Income | -$97 | -$58 | -$162 | -$122 |
| % Margin | -89.6% | -50.8% | -4,434.7% | -298.4% |
| EPS Diluted | -0.7 | -0.54 | -2.05 | -2.36 |
| % Growth | -29.6% | 73.7% | 13.1% | – |
| Operating Cash Flow | -$151 | -$19 | -$128 | -$89 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$152 | -$21 | -$129 | -$90 |